Cetera Advisors’s Allergan plc AGN.PRA Stock Holding History

Cetera Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,292	Closed	-$765K	–	902
2017 Q4	$765K	Sell	1,292 -249	-16%	-$161K	0.05%	346
2017 Q3	$1.14M	Sell	1,541 -214	-12%	-$178K	0.07%	293
2017 Q2	$1.53M	Sell	1,755 -24	-1%	-$20.1K	0.1%	230
2017 Q1	$1.52M	Sell	1,779 -12	-0.7%	-$9.94K	0.1%	219
2016 Q4	$1.36M	Buy	1,791 +236	+15%	+$178K	0.1%	211
2016 Q3	$1.28M	Buy	1,555 +637	+69%	+$551K	0.1%	213
2016 Q2	$776K	Buy	+918	New	+$767K	0.06%	314

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Cetera Advisors's AGN.PRA Position: Q1 2018 in Review

Cetera Advisors sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 1,292 shares — an estimated $765K sold.

Cetera Advisors first reported a position in AGN.PRA in Q2 2016 and held it in 7 quarters. The position peaked at $1.53M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Cetera Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Cetera Advisors sold 1,292 Allergan plc shares in Q1 2018, an estimated $765K.
Cetera Advisors first reported a position in Allergan plc in Q2 2016 and held it in 7 quarters.
Cetera Advisors's Allergan plc position peaked at $1.53M in Q2 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Cetera Advisors's 13F filing for Q1 2018, filed 9 May 2018.